Key facts
- Notable investors include Arieli Group, NGT HealthCare II.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Proventis Med
- ·The full record, as it builds
Funding rounds
No funding rounds for Proventis Med are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Proventis Med
Developer of healthcare technology intended for a male contraceptive implant. The company's technology offers male contraception with a non-hormonal, reliable, long-term, but reversible device that addresses a major gap in male reproductive health, enabling couples to be empowered with shared responsibility in family planning.
- Sector
- Healthcare
- HQ
- Beit Oren, Israel
- Founded
- 2025
- Employees
- 3
- Website
- proventismed.com/
- Ownership
- Privately Held (backing)
Proventis Med doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Proventis Med shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Proventis Med in its N-PORT filings yet. We sweep new filings monthly.